Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas
All three of these specialty pharmaceutical stocks come with a fair share of risk but provide big upside potential as well.
All three of these specialty pharmaceutical stocks come with a fair share of risk but provide big upside potential as well.
Jazz Pharmaceuticals announced Tuesday morning that it has reached a definitive agreement to acquire Celator Pharmaceuticals for about $1.5 billion.
This is going to be a big year in biotech, with a host of drugs set to undergo FDA scrutiny. These four companies with promising candidates all have dates with the agency…
Stocks were indicated surprisingly higher after international markets recovered more than might have been expected. The trend that has been static for 4 years now is that investors want to buy stocks…
Friday's top analyst upgrades and downgrades include Cisco Systems, EMC, GameStop, Novavax, Tesla Motors and Yahoo.
Friday's top analyst upgrades, downgrades and initiations from 24/7 Wall St. include Wal-Mart, Garmin, DSW, Kinder Morgan and Hasbro.
A recent research piece from the biotech analysts at Stifel focused on three top stocks to buy with outstanding potential.
The analysts at Piper Jaffray are very positive on four top specialty pharmaceutical stocks with potential for a strong fourth-quarter rally in their shares.
Cowen asked the analysts which stocks should be on their shopping lists. Here are the six with the biggest upside potential.
A new research report from the analysts at Cowen sees a potential wave of biotech deals, some of which could be of the blockbuster variety.
These are the top analyst upgrades and downgrades from 24/7 Wall St. on Tuesday, August 19. 2004. They include Applied Materials, Pollo Loco, Dollar General, SolarCity and Urban Outfitters.
ThinkstockEvery time the economy gets good again, and every time the stock market gets high again, waves of mergers and acquisitions begin taking place. The stock market’s bull run is now more…
St. Patrick's Day may have come and gone for this year, but the analysts at biotech boutique shop Leerink have highlighted six Ireland-based firms that could be tempting takeover targets for large…
In a new research report, the boutique firm Leerink highlights 10 top biotech names that are strong candidates for a partnership or acquisition. Any of these picks may be a great addition…
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Friday, March 7, 2014. They include Nokia, Safeway, Sirius XM, Skull Candy and Teva Pharmaceutical.